William Ross Pitt

William Ross Pitt

Auto-generated profile, based on publicly available information

William Ross Pitt

UCB Celltech, Granta Park, Great Abington, Cambridge CB1 6GS, UK

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2009 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
WPWilliam R. Pitt
William R. Pitt
DPDavid M. Parry
David M. Parry
BPBenjamin G. Perry
Benjamin G. Perry
CGColin R. Groom
Colin R. Groom

1 December 2008 in Journal of Molecular Biology
Verified
Journal Article
Closed access
TOTjelvar S.G. Olsson
Tjelvar S.G. Olsson
MWMark A. Williams
Mark A. Williams
WPWilliam R. Pitt
William R. Pitt
JLJohn Ladbury
John Ladbury

6 August 2019 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
NMNenad Manevski
Nenad Manevski
LKLloyd King
Lloyd King
WPWilliam R. Pitt
William R. Pitt
FLFabien Lecomte
Fabien Lecomte
FTFrancesca Toselli
Francesca Toselli

11 June 2009 in Chemical Biology & Drug Design
Verified
Journal Article
Open access
PDF file
Duangrudee TanramlukDuangrudee Tanramluk
Duangrudee Tanramluk
ASAdrian Schreyer
Adrian Schreyer
WPWilliam R. Pitt
William R. Pitt
TBTom Blundell
Tom Blundell
Relationships between ligand binding and the shapes of the binding sites in families of homologous enzymes are investigated by comparing matrices of distances between key binding site atoms. Multiple linear regression is used to help identify key distances that influence ligand binding affinity. In order to illustrate the utility of this generic approach, we study protein kinase binding sites for ATP and the promiscuous competitive inhibitor, staurosporine. We show that the size of the gatekeeper residue and the closure between the first glycine of the GXGXXG motif and the aspartate of the DFG loop act together to promote tight binding. Our web‐based tool, ‘mapping analogous hetero‐atoms onto residue interactions’ (MAHORI), indicates that the greater the number of hydrogen bonds made by the kinase around the methylamine group of staurosporine, the tighter the binding. The conservation of surrounding atoms identified using our novel grid‐based method clearly demonstrates that the most structurally conserved part of the binding site for staurosporine is the main chain of the hinge region. The critical role of interactions that are not dependent on side‐chain identities is consistent with the promiscuous nature of this inhibitor.

1 November 2002 in Quantitative Structure-Activity Relationships
Verified
Journal Article
Closed access
PDF file
BTBenjamin G. Tehan
Benjamin G. Tehan
ELEdward J. Lloyd
Edward J. Lloyd
MWMargaret G. Wong
Margaret G. Wong
WPWill R. Pitt
Will R. Pitt
EGEmanuela Gancia
Emanuela Gancia
DMDavid T. Manallack
David T. Manallack

1 June 2007 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
MAMahbub Alam
Mahbub Alam
RBRebekah E. Beevers
Rebekah E. Beevers
TCTom Ceska
Tom Ceska
RDRichard J. Davenport
Richard J. Davenport
KDKaren M. Dickson
Karen M. Dickson
LTLaura J. Tait
Laura J. Tait